AGNT, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AGNT, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	53.6	156	500	980	1,798	3,771	4,590	4,274	4,568	4,772
Cost of revenue	46.4	140	460
Gross profit	7.12	16.5	40.4					320	342	334
Research and development							54.2	59.5	58.2	69.6
Selling and marketing	0.57	1.57	2.96	3.8	5.22	12.2	15.2	12.1	11.9	10.6
General and administrative	13.3	35.7	59.9	89	123	250	275	248	252	275
Operating expenses	60.9	178	523	989	1,767	3,737	4,573	319	361	355
Operating income	-7.37	-22	-22.4	-8.78	31.6	34.2	16.4	0.52	-19	-21.5
Interest expense	0	0
Other non-operating income	-0	-0	0.03	-0.28	-0.18	-0.48	-0.82	3	3.28	1.23
Pre-tax income	-7.37	-22	-22.4	-9.06	31.4	33.7	15.5	3.52	-15.7	-20.2
Income tax	0.04	0.1	0.08	0.5	0.41	-47.5	-8.2	-0.02	1.07	2.48
Income from continuing operations							23.7	3.53	-16.8	-22.7
Net income to minority interests	-0.03	0		-0.03	-0.14	-0.06	0.02
Net income	-7.38	-22.1	-22.4	-9.53	31.1	81.2	15.4	-8.97	-21.3	-22.7
EBITDA	-7.31	-21.7	-21.5	-6.72	35.8	40.4	26.2	11.4	-11.2	-14.6
EPS, basic	-0.07	-0.20	-0.19	-0.08	0.22	0.56	0.10	-0.06	-0.14	-0.14
EPS, diluted	-0.07	-0.20	-0.19	-0.08	0.21	0.51	0.10	-0.06	-0.14	-0.14
Shares, basic (weighted)	105	109	115	126	139	146	151	153	154	157
Shares, diluted (weighted)	105	109	115	126	152	158	156	157	154	157
Dividend per share								0.05	0.05	0.05

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	1.68	4.67	20.5	40.1	100	108	122	126	114	124
Receivables	3.02	6.91	17.4	28.2	77	133	87.3	85.3	87.7	109
Other current assets	0.01	0.02	0.03	0.79	2.42	0.48	0.58	1.3	1.19	3.23
Total current assets	5.57	13.1	42.3	78.8	212	319	255	266	268	305
Property, plant and equipment	0.54	1.54	2.74	5.43	7.85	15.9	18.2	12	11	13.9
Lease right-of-use assets				1.26	0.82	2.48	2.13	0.01
Goodwill			8.25	8.25	12.9	12.9	27.2	17	17.2	17.9
Intangible assets			2.53	2.68	8.35	7.53	8.7	7.01	6.46	4.42
Other non-current assets	0.54	1.54
Total assets	6.1	14.6	55.8	96.5	242	414	382	386	391	442
Accounts payable	0.32	0.64	1.76	2.59	3.96	7.16	10.4	8.79	10.5	14.6
Accrued liabilities	2.74	8.82	19	31	62.8	112	78.9	86.5	85.7	108
Deferred revenue			2.5	6.99	27.8	67.7	37.8	44.6	55.7	57.2
Short-term debt			0.97	0.92	1.42
Total current liabilities	3.58	10.4	24.2	42	96.7	187	127	142	186	200
Long-term debt			1.65	1.53	2.88	2.71	4.7	0.02
Lease liabilities				0.83	0.07	0.77	0.69
Total liabilities	3.58	10.4	25.9	44.3	99.6	190	133	142	186	200
Total debt			2.63	2.45	4.29	2.71	4.7	0.02
Paid-in capital	13	36.8	90.8	131	218	401	612	805	963	1,105
Retained earnings	-10.5	-32.6	-60.8	-70.3	-39.2	30.5	20.7	-16.8	-68.1	-122
Treasury stock				-8.62	-38	-210	-385	-546	-687	-743
Shareholders' equity	2.53	4.26	30	52	142	222	248	243	205	243
Minority interests	0	0		0.16	1	1.36	1.17	1.17
Total equity	2.53	4.26	30	52.1	143	224	249	244	205	243
Total liabilities and equity	6.1	14.6	55.8	96.5	242	414	382	386	391	442
Shares outstanding	107	113	60.6	131	144	149	153	155	154	161

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-7.41	-22.1	-22.4	-9.56	31	81.2	15.4	-8.97	-21.3	-22.7
Depreciation and amortization	0.06	0.35	0.87	2.06	4.21	6.25	9.84	10.9	7.84	6.87
Stock-based compensation	5	11	4.85	5.09	6.8	13.1
Deferred income tax	0	0		-0.09	-0.33	-49.6	-11.2	-2.9	-3.61	-1.41
Change in receivables	-2.69	-3.88	-10	-10.6	-50.2	-56.9	44.9	3.47	-1.7	-21.1
Change in payables	0.23	0.32	0.61	1.41	1.36	3.17	2.43	-1.49	1.69	4.14
Cash from operations	1.02	4.57	24.3	55.2	120	247	211	209	192	119
Capital expenditures	-0.42	-1.28	-2.13	-5	-6.44	-13.4	-12.1	-5.36	-6.48	-9.57
Acquisitions			-6.73	-1.5	-10.5	-2.5	-9.91		-6.15
Cash from investing	-0.42	-1.28	-8.86	-6.69	-17	-18.9	-22.5	-13.5	-19.5	-23.5
Stock issued	0.6	0.14	2.02	2.3	6.95	3.62	0.61	4.98	2.01	0.43
Share buybacks	0	-0		-27.1	-29.4	-172	-179	-161	-141	-56.2
Dividends paid						-11.5	-25.2	-28.5	-30.1	-30.8
Cash from financing	0.49	0.15	2.02	-24.6	-21.9	-180	-205	-184	-170	-86.5
Exchange rate effect			-0.02	0.11	0.05	-0.06	-0.09	-0.04	-2.97	4.27
Net change in cash	1.11	3.43	17.4	24	80.9	48	-16.5	11.5	-1.31	12.9
Free cash flow	0.61	3.29	22.2	50.2	113	233	198	204	185	109
Interest paid	0	0
Income taxes paid	0.04	0.1	0.07	0.13	0.75	1.33	3.41	2.73	2.69	4.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.63 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	-0.3%	Operating income / revenue.
EBITDA margin	-0.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.3%	Pre-tax income / revenue.
Net margin	-0.3%	Net income / revenue.
FCF margin	1.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	2.1%	Cash from operations / revenue.
Return on equity (ROE)	-6.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-3.2%	Net income / average total assets.
Return on invested capital (ROIC)	-7.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	1.4%	Research and development expense / revenue.
Capex / revenue	0.2%	Capital expenditures / revenue.
D&A / revenue	0.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	21.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-2.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-38.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-17.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-0.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-41.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-18.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-0.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	18.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	11.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	13.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	12.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.52x	Current assets / current liabilities.
Quick ratio	1.08x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.43x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	47.9%	Total liabilities / total assets.
Working capital	$133.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	5.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$249.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	9.21x	Revenue / average total assets.
Fixed asset turnover	415x	Revenue / average property, plant and equipment.
Receivables turnover	29.6x	Revenue / average receivables.
Days sales outstanding	12 days	365 x average receivables / revenue.
Capex / operating cash flow	9.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.10	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$29.87	Revenue / diluted weighted shares.
FCF per share	$0.56	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.61	Cash from operations / diluted weighted shares.
Book value per share	$1.68	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.49	Tangible book value / shares outstanding.
Cash per share	$0.67	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	34.1%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$606.6M	Share price x shares outstanding.
Enterprise value	$495.5M	Market cap + total debt - cash - short-term investments.
P/S	0.12x	Market cap / revenue.
P/B	2.16x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.44x	Market cap / tangible book value, when positive.
P/FCF	6.53x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.95x	Market cap / cash from operations, when positive.
EV/Sales	0.10x	Enterprise value / revenue.
EV/FCF	5.33x	Enterprise value / free cash flow, when both are positive.
FCF yield	15.3%	Free cash flow / market cap.
Earnings yield	-2.8%	Net income / market cap (the inverse of P/E).
Dividend yield	5.2%	Dividends paid over the period / market cap.
Shareholder yield	5.2%	(Dividends paid + share buybacks) / market cap.

What was AGNT, Inc.'s revenue in fiscal 2025?

AGNT, Inc. reported revenue of $4.77B for fiscal 2025, 4.5% higher than the year before.

Was AGNT, Inc. profitable in fiscal 2025?

No. It reported a net loss of $22.7M.

How much free cash flow did AGNT, Inc. generate in fiscal 2025?

Cash from operations of $118.6M minus capital expenditures of $9.6M left free cash flow of $109.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AGNT, Inc.